[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes A.P. Deauville, Apothecus Pharmaceutical Corp., Carolina Liquid Che...[ Price : $8.95]
Reps. Cicilline and Nadler introduce legislation to strengthen FTC authority to win cases against drug companies that try to move ...[ Price : $8.95]
The Center for Science in the Public Interest says FDA and the Federal Trade Commission should take enforcement action against 27 ...[ Price : $8.95]
The Federal Trade Commission says that Bristol-Myers Squibb and Celgene will divest Celgenes Otezla to Amgen to resolve antitrust ...[ Price : $8.95]
CDRH technical guidance specialist Jason Ryans explains how FDA will use the new safety and performance-based 510(k) pathway.[ Price : $8.95]
FDA accepts for review a Samsung Bioepis BLA for SB8, a biosimilar candidate referencing Genentechs Avastin (bevacizumab).[ Price : $8.95]
An FDA device safety update says more adverse event reports have been received about intra-aortic balloon pumps by Getinges Maquet...[ Price : $8.95]
FDA sends Nascent Biotech an untitled letter objecting to promotional content on the companys Web site about its investigational d...